Product correctly added to cart.

discount label
Ofloxacin-d8
View 3D

Biosynth logo

Ofloxacin-d8

CAS: 1219170-21-4

Ref. 3D-UYB17021

1mgTo inquire
5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Thursday 22 Aug 2024

Product Information

Name:
Ofloxacin-d8
Description:

Ofloxacin-d8 is an analog of the fluoroquinolone antibiotic Ofloxacin that contains eight deuterium atoms. It has been shown to have potent anticancer properties in human and Chinese cancer cell lines by inhibiting protein kinases, including cyclin-dependent kinases, which are important regulators of cell division. Ofloxacin-d8 induces apoptosis, a process of programmed cell death that plays a crucial role in preventing tumor growth. This drug can be detected in urine samples and is used as a research tool for studying the pharmacokinetics and metabolism of Ofloxacin. Additionally, it can be used as an inhibitor for kinase assays in cancer research. Overall, Ofloxacin-d8 is a powerful tool for investigating the mechanisms underlying cancer cell growth and developing new anticancer therapies.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
369.4 g/mol
Formula:
C18H20FN3O4
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-UYB17021 Ofloxacin-d8

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".